Rheumatoid Arthritis Treatment News and Resources
February 22, 2012

Randox and University of Ulster develop arthritis test
BBC News

A County Antrim company and the University of Ulster are co-operating on a £1m project which could help treat those suffering from arthritis. They are developing a test which allows patients to determine which drugs do or don't work for rheumatoid

New drugs offer hope for rheumatoid arthritis
USA TODAY

By Susan Bloom, Asbury Park (NJ) Press LONG BRANCH, NJ -- Unbeknownst to many, rheumatoid arthritis is a disorder that can extend far beyond the joints. Wasser noted that rheumatoid arthritis is three times more likely to strike women than men,

Find A PhD Project: Rheumatoid Arthritis and Periodontal Disease at ...
(author unknown)

Rheumatoid Arthritis - The Most Common Types of Arthritis
(author unknown)

The term arthritis basically comes from the Greek word arthron which means joint and the Latin word itis which means inflammation. Rheumatoid arthritis as a

FDA Accepts Supplemental Biologics License Application Submitted for ACTEMRA ...
PharmaLive.com (press release)

This sBLA seeks to broaden the approved patient population of Actemra® for the treatment of moderately to severely active rheumatoid arthritis (RA), to patients who have either responded inadequately to, or who were intolerant to, previous therapy with

STATE v. SCHAUFELE
Leagle.com

{¶ 2} Ms. Schaufele suffers from rheumatoid arthritis and has been treated by Dr. Marie Kuchynski for that condition since approximately 2003 or 2004. Dr. Kuchynski treated Ms. Schaufele with anti-inflammatory drugs as well as narcotics,

Randox to create Arthritis Test
Insideireland.ie

I Suck at Getting Old — The Good Men Project
Edgar Ramsey

Over the past decade, I have racked up more and more physical ailments starting with a diagnosis of rheumatoid arthritis about ten years ago. My medicine cabinet is starting to look like a pharmacy. I have high blood pressure, high cholesterol

Prison Planet.com » Supply-driven pharmaceutical drug and ...
admin

And adult ADHD, rheumatoid arthritis, fibromyalgia, and sleeping disorders are just a few of today's most common “blockbuster” conditions with vague diagnosing guidelines that the industry uses to push more drugs. When one condition

Few Trials of Biologic DMARDs for Rheumatoid Arthritis Are Head-to ...
(author unknown)

Cleveland Clinic and North Shore-Long Island Jewish Health System Form ...
MarketWatch (press release)

Through this collaboration with CCI, Feinstein Institute officials say they hope to pursue commercialization ventures focused on diseases, such as rheumatoid arthritis, lupus, cancer, sepsis, Alzheimer's and schizophrenia. "Working with a nationally

Supreme Court will not hear J&J case over Humira
CBS News

It is approved to treat several immune system disorders, including rheumatoid arthritis and Crohn's disease. J&J has claimed that it developed the technology first used in the biotech drug. The company markets similar medications Remicade and Simponi,

Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2011 ...
MarketWatch (press release)

LX2931: Previously-reported Phase 2a results of LX2931, an inhibitor of sphingosine-1-phosphate lyase, demonstrated a favorable safety profile at all doses tested and suggest that rheumatoid arthritis patients treated with 150 mg of LX2931 once daily

UCB announces start of C-EARLY™ study for Cimzia® (certolizumab pegol) in ...
PharmiWeb.com (press release)

“There is growing evidence to support the value of detecting and treating rheumatoid arthritis patients as soon as possible after the onset of disease in order to prevent disease progression. By rapidly achieving the target of sustained remission

Key Account Manager - Rheumatology
Pharma Times

UCB commences new Cimzia study for rheumatoid arthritis
Zenopa

UCB has announced the commencement of a new clinical study that will assess the safety and efficacy of Cimzia in a new indication against rheumatoid arthritis. The phase III C-Early trial will evaluate a combination therapy involving Cimzia and

NICE approve rheumatoid arthritis drug
Nursing Times

Rheumatoid arthritis sufferers can soon look forward to receiving further treatment following a NICE approval of a drug designed to tackle the disease. You now need to register for FREE to read our news. Please sign in or register to continue

THV Extra: Challenges of returning veterans (Part 2)
Today's THV

"I was diagnosed with rheumatoid arthritis almost immediately and it got worse and worse and worse so I came home and everything wasn't normal. I was sick," says Ebony. "I couldn't get in and out of the tub. I couldn't write, I couldn't pick up things,

You Docs: Omega-3 just gets better and better
The Idaho Statesman

These anti-inflammatory oils lubricate muscles, promote fertility, lower blood pressure, protect vision, help prevent dementia, cut the risk of some cancers, ease pain, reduce inflammation of osteo- and rheumatoid arthritis, promote weight loss and

Nice makes arthritis drug RoActemra easier to get
Telegraph.co.uk

Up to 65000 people with rheumatoid arthritis will be able to access a "breakthrough" treatment more easily, after the manufacturer brought the price down. The latest Nice guidance follows an initial decision to refuse tocilizumab, marketed as RoActemra